Collectively, our data demonstrate that the progression of patients from outpatients with ascites to patients hospitalised with AD/ACLF is accompanied by an increase in bioavailable PGE2, reduced monocyte HLA-DR expression, and reduced monocyte TNFα/IL6 production. Here, IL6 is linked to Alzheimer disease.